Ketamine Hydrochloride Injection
Product Images NDC 0143-9509

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ketamine Hydrochloride (NDC 0143-9509). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ketamine Hydrochloride Injection Usp 1)

Chemical structure of Ketamine Hydrochloride, showing a cyclohexanone ring linked to an aromatic ring with a chlorine atom, and the molecule complexed with hydrochloride (HCl).*

FDA Label Image

Ketamine Hydrochloride Injection, Usp 50 mg/ml; 10 mL Vial Label (Ketamine Hydrochloride Injection Usp 2)

Label for Ketamine Hydrochloride Injection USP, 100 mg/mL, 500 mg per 5 mL concentrate in a sterile multiple dose vial by Hikma Pharmaceuticals USA Inc. The label indicates the product is for intramuscular or slow intravenous use and should be diluted before intravenous use. It includes dosing instructions and storage information with a barcode and lot and expiration date fields.*

FDA Label Image

Ketamine Hydrochloride Injection, Usp 100 mg/ml; 5 mL Vial Label (Ketamine Hydrochloride Injection Usp 3)

Label of Ketamine Hydrochloride Injection USP, 100 mg/mL strength, sold as 500 mg per 5 mL concentrate for intramuscular or slow intravenous use. The label instructs dilution before IV use and specifies 10 x 5 mL multiple dose vials. Manufactured by Hikma Farmacéutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. The label includes storage instructions and cautions regarding light protection and potential color changes.*

FDA Label Image

Ketamine Hydrochloride Injection Usp 4

Label for Ketamine Hydrochloride Injection USP, 50 mg/mL, marketed by Hikma Pharmaceuticals USA Inc. The label indicates a 10 mL multiple dose vial containing 500 mg total ketamine hydrochloride. It is intended for intramuscular or slow intravenous use. The label includes storage instructions, preservative information, usage warnings, and packaging details.*

FDA Label Image

Ketamine Hydrochloride Injection Usp 5

Ketamine Hydrochloride Injection USP 50 mg/mL, supplied as 500 mg per 10 mL in a 10 x 10 mL multiple dose vial. The label states it is for intramuscular or slow intravenous use, sterile, and prescription only. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. Includes storage instructions, composition details, and usage cautions.*

FDA Label Image

Ketamine Hydrochloride Injection Usp 6

A product label for Ketamine Hydrochloride Injection by Hikma Pharmaceuticals USA Inc. The label includes a GTIN barcode with the number 00301234567896, a serial number, an expiration date placeholder, and a lot number placeholder. It does not specify strength or volume on the visible portion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.